Evidence map›Paper›PMID 19897692›Full record

ArticleJournal of the American Board of Family Medicine : JABFM

Context of clinical care: the case of hepatitis C in underserved communities--a report from the Primary Care Multiethnic Network (PRIME Net) Consortium.

Robert R Leverence, Robert L Williams, Wilson Pace, Bennett Parnes, Yvonne Fry-Johnson, Dorothy R Pathak, Betty Skipper, Elvan Daniels, Philip Kroth, PRIME Net Consortium

Open access · bronzeAbstract read
In one paragraph

Article in Journal of the American Board of Family Medicine : JABFM. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Case-finding for hepatitis C in primary care: a mixed-methods service evaluation.The British journal of general practice : the journal of the Royal College of General Practitioners · 2014
    Article
  4. Article
  5. Formal hepatitis C education enhances HCV care coordination, expedites HCV treatment and improves antiviral response.Liver international : official journal of the International Association for the Study of the Liver · 2013
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Robert R LeverenceDepartment of Medicine, University of New Mexico, Albuquerque, NM 87131-0001, USA.
Robert L Williams
Wilson Pace
Bennett Parnes
Yvonne Fry-Johnson
Dorothy R Pathak
Betty Skipper
Elvan Daniels
Philip Kroth
PRIME Net Consortium
Morehouse School of Medicine · USUniversity of Colorado Denver · USCancer Research And Biostatistics · US

Funding

Integrating and Expanding Clinical Research NetworksN01HC045211 · HC · UNIVERSITY OF NEW MEXICO · PI WILLIAMS, ROBERT L · 2004 to 2004
–
NHLBI NIH HHS N01 HC045211PHS HHS D54HP00032-07-00PHS HHS HHSN268200425211C
6 · The paper itself

Abstract

backgroundThe importance of Hepatitis C (HCV) as a public and individual health concern is well established. However, national groups differ in their recommendations to primary care clinicians about screening people at high risk for HCV. The purpose of this study was to explore the context of care within which primary care clinicians decide to detect and initially manage HCV.

methodsThe Primary Care Multiethnic Network conducted a web- and paper-based survey of primary care clinicians who largely practice in low-income, medically underserved communities in 3 regions across the country.

resultsA total of 494 clinicians participated, for a response rate of 61%. Most (68%) clinicians view HCV as an important problem; more than half (59%) consider screening for HCV to be important when compared with other conditions they screen for in practice. With regard to reported screening habits for risk factors, 54% of clinicians routinely ask new patients whether they have used intravenous drugs and 28% inquire about blood transfusions before 1992. Sixty-one percent order an alanine aminotransferase test when patients present with other risk factors for HCV. The majority of clinicians (54%) refer 75% or fewer of their patients with HCV for treatment; nearly one-fifth (18%) provide antiviral treatment themselves. Key factors influencing clinician HCV decision making are patient comorbidities (74% reported this as a factor), access to treatment (55% reported this as a factor), and tolerance (44% reported this as a factor) of treatment.

conclusionsIn the face of conflicting national guideline recommendations about screening people at high risk for HCV, clinicians have varied views and practice habits influenced by multiple patient, access, and treatment issues.

Indexed as

Medically Underserved AreaDecision MakingHepatitis CHumansMass ScreeningPrimary Health Care

Identifiers

PMID19897692
PMCPMC2806647
OpenAlexW2142956507

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.